• Questions? +1 (732) 747-1007
  • ir@americancryostem.com
  • Physicians
  • Licensing & Partners
  • SERVICES
    • HOW IT WORKS
    • COSMETIC CRYO-FAT
    • ADULT STEM CELLS
  • PRODUCTS
    • TISSUE HARVESTING SYSTEM
    • STEM CELL MEDIAS
    • STEM CELL LINES
  • OUR SCIENCE
  • INVESTORS
    • ABOUT US
    • STOCK INFORMATION
    • PRESS RELEASES
    • OUR LEADERSHIP
    • LICENSING PARTNERS
  • NEWS
  • CONTACT

Adipose Tissue Stem Cells Produce Liver Cells to Save Lives

October 31, 2013
Liver transplant avoided by treatment with adipose tissue stem cells.

© Dan Race – Fotolia.com

In a recent study published in Cell Transplantation, adipose tissue stem cells were successfully used to produce liver cells.

This could potentially be a major medical advancement for people who suffer from liver failure.

Approximately 6,300 liver transplants are performed each year. There are about 16,000 people on a waiting list. Sadly, over 1,400 end up dying because a liver was unable to be found and transplanted in time.

Even when people receive a liver transplant, complications are common. The body often rejects new organs, so patients end up having to take immunosuppressant drugs to lower the risk of losing the new liver, and possibly, their life.

From the recently published study, research scientists at Stanford University School of Medicine may now be able to supply liver failure patients with the cells they need to regenerate their own, brand new liver. Since the new liver tissue is made from the patient’s own stem cells, it’s highly unlikely that the body will reject it, eliminating the need for immunosuppressant drugs.

In the study, scientists isolated fat stem cells taken from human adipose tissue via liposuction. The adipose stem cells were then placed in mice, where they produced liver-like cells.

 

What the Liver Does for the Body

 

A healthy liver takes care of the body’s chemistry. It filters out toxins and waste products. If it wasn’t for the liver, the body would become toxic, and the person would feel ill and eventually die.

What is so fascinating about the liver is that it regenerates itself over time, unless it is severely damaged from chronic alcoholism or viral hepatitis. This is what causes many people to end up with liver failure, thus creating the need for a new one.

With the potential discovered through this new medical study, it may be possible for liver patients to be cured through a simple liposuction procedure to harvest their adipose tissue. Once collected, the tissue will be processed to isolate the stem cells, which takes about nine days.

This is usually a sufficient time frame to save a patient’s life, as many have a up to a few weeks before they end up dying, if no liver is available for transplant.

 

Adipose Tissue Stem Cells Can Protect from Liver Disease

Liver disease is not as rare as many people think. Even if a patient isn’t a chronic alcoholic or suffers from viral hepatitis, acetaminophen and poisonous mushrooms can also lead to liver failure. In fact, acetaminophen related liver damage claims about 500 lives a year and harms many more.

With adipose tissue stem cells, people may soon be able to repair their liver and save their life. Physicians can provide this safety net to patients through using our ATGRAFT tissue preservation program. By offering stem cell and fat storage services, patients are now able to secure protection from future liver disease as well as many other health problems.

Stem cell research continues to identify new and amazing uses for adipose derived stem cells. This is an excellent reason for everyone to consider having their body fat and adult stem cells stored cryogenically.

Offer your patients more by bringing your practice to the next level. Find out how to enroll in the ATGRAFT program as a Network Provider here.

 

Written by John DiFolco.

References: http://www.eurekalert.org/pub_releases/2013-10/sumc-srd101813.php

 

Share

Related posts

November 4, 2014

BRCA Gene Testing May Lead to Increase in Preventative Mastectomy Procedures


Read more
October 17, 2014

ATGRAFT fat storage featured on FoxFiveNY News


Read more
April 9, 2014

American CryoStem and Rutgers University File Joint Patent on Adipose-Derived Stem Cell Platform Technology


Read more

About American CryoStem Corporation

American CryoStem Corporation (OTC:CRYO), is a clinical-stage biotechnology company, global licensor and a pioneer in autologous (one’s own) cellular processing and therapies. The Company's centralized laboratory model and patented foundational “CryoStem Platform” is a best-in-class, end-to-end cellular therapy solution to treat injuries, disorders and chronic diseases through a single adipose-tissue (fat) harvest and ATCELLBank™ cryopreservation. We are dedicated to helping the world’s physicians, hospitals, and clinics improve clinical outcomes by developing and delivering effective leading-edge stem cell therapies that improve patient health and quality of life.

© 2021 American CryoStem Corporation | A Publicly Traded Company (CRYO)
  • Physicians
  • Licensing & Partners